ASTX030-01

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Astex Pharmaceuticals, Inc

Start Date

October 4, 2022

End Date

September 30, 2027

Administered By

Duke Cancer Institute

Awarded By

Astex Pharmaceuticals, Inc

Start Date

October 4, 2022

End Date

September 30, 2027